X
Indications

ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone. Read More

ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years and older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light). 
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used with or without methotrexate.
ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. 
ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older. Close
Person with PsA at work

Why ENBREL?

ENBREL helps treat joint pain, stiffness, and skin symptoms for people with psoriatic arthritis (PsA). ENBREL can also help stop joint damage from getting worse. So talk to your doctor.

Person with PsA at work

Why ENBREL?

ENBREL helps treat joint pain, stiffness, and skin symptoms
for people with psoriatic arthritis (PsA). ENBREL can also help
stop joint damage from getting worse. So talk to your doctor.

  • How Enbrel Works
  • Results
  • What to Expect

Learn how ENBREL works

To understand how ENBREL works for psoriatic arthritis, it’s important to look at the immune system to learn how joint pain and joint damage can start.

icon

Your immune system protects your body from infections and diseases. But if it isn’t working right, it can actually harm your body. When you have psoriatic arthritis, cells from your immune system move into your joints and skin and make a variety of proinflammatory proteins. One of these proteins is called tumor necrosis factor, or TNF. Too much TNF may lead to inflammation. That can contribute to pain, stiffness, and swelling of joints. Too much TNF can also make skin cells grow too quickly, forming patches of red, thick skin with silvery scales.

icon

ENBREL is a type of medicine called a biologic (a treatment made from living cells). It’s designed to attach to TNF proteins to help block their activity and help relieve the joint pain, stiffness, and skin lesions of PsA. Treating PsA with ENBREL can help you get back to many of the moments that make you who you are.

icon

Fortunately, ENBREL helps stop further joint damage—and helps stop further joint damage that cannot be reversed. The inflammation causing the joint pain you’re feeling could be leading to future joint damage that cannot be undone. That’s why it’s so important to treat pain AND help stop further damage. ENBREL can help with both.

Remember, the pain you are feeling may be a sign of joint damage. This type of damage can be permanent, so it’s important to talk to your doctor about any pain you’re experiencing early on to manage the progression of joint damage.

What Dr. Grace Wright—a leading rheumatologist—tells her patients before starting ENBREL

Once you start ENBREL, it’s natural to ask yourself, when will I start to see results? Many people saw less joint pain within 4 weeks and their skin symptoms clear up.

Remember, ENBREL works differently for everyone. Some people see results more quickly, while for others, it may take longer than expected. Not everyone on ENBREL will see results.

Dr. Grace Wright can help you set expectations for when you’ll see results on ENBREL. She encourages patients like you to stay positive and keep taking your medication as prescribed. This way, your doctor can continue to monitor your progress and give you the best chance for success.

icon-discussion-guide

Doctor Discussion Guide

Use this simple guide to help your doctor understand how your PsA is impacting your life, and ask whether ENBREL is right for you.

Download the Doctor Discussion Guide  »
jp-copy

Joint Damage Simulator

Joint pain can be a sign of permanent joint damage. Use the Joint Damage Simulator to see how joint damage can get worse over time.

View the Joint Damage Simulator  »
icon-embark-app

Meet the Embark® App

The Embark App has been designed to support your ENBREL experience. Download it for free today to get financial support information, medication reminders, injection site tracking, and more—all in the palm of your hand.

Learn More  » 
icon_arrow

STATWISE
Symptom Tracking
Tool

STATWISE™ is a mobile-based symptom tracking tool designed for people living with psoriatic arthritis.

Discover STATWISE™  »
+ See More

Important Safety Information

What is the most important information I should know about ENBREL?

ENBREL is a medicine that affects your immune

ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections
have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have

 
Close
Prescription Enbrel® (etanercept) is taken (given) by injection.

Important Safety Information

What is the most important information I should know about ENBREL?

ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections. Your healthcare provider should test you for TB before you take ENBREL and monitor you closely for TB before, during, and after ENBREL treatment, even if you have tested negative for TB.

There have been some cases of unusual cancers, some resulting in death, reported in children and teenage patients who started using tumor necrosis factor (TNF) blockers before 18 years of age. Also, for children, teenagers, and adults taking TNF blockers, including ENBREL, the chances of getting lymphoma or other cancers may increase. Patients with RA may be more likely to get lymphoma.

Before starting ENBREL, tell your healthcare provider if you:

  • Have any existing medical conditions
  • Are taking any medicines, including herbals
  • Think you have, are being treated for, have signs of, or are prone to infection. You should not start taking ENBREL if you have any kind of infection, unless your healthcare provider says it is okay
  • Have any open cuts or sores
  • Have diabetes, HIV, or a weak immune system
  • Have TB or have been in close contact with someone who has had TB
  • Were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your healthcare provider if you are not sure
  • Live, have lived in, or traveled to certain parts of the country (such as, the Ohio and Mississippi River valleys, or the Southwest) where there is a greater risk for certain kinds of fungal infections, such as histoplasmosis. These infections may develop or become more severe if you take ENBREL. If you don’t know if these infections are common in the areas you’ve been to, ask your healthcare provider
  • Have or have had hepatitis B
  • Have or have had heart failure
  • Develop symptoms such as persistent fever, bruising, bleeding, or paleness while taking ENBREL
  • Use the medicine Kineret (anakinra), Orencia (abatacept), or Cytoxan (cyclophosphamide)
  • Are taking anti-diabetic medicines
  • Have, have had, or develop a serious nervous disorder, seizures, any numbness or tingling, or a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome
  • Are scheduled to have surgery
  • Have recently received or are scheduled for any vaccines. All vaccines should be brought up-to-date before starting ENBREL. Patients taking ENBREL should not receive live vaccines.
  • Are allergic to rubber or latex
  • Are pregnant, planning to become pregnant, or breastfeeding
  • Have been around someone with chicken pox

What are the possible side effects of ENBREL?

ENBREL can cause serious side effects including: New infections or worsening of infections you already have; hepatitis B can become active if you already have had it; nervous system problems, such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes; blood problems (some fatal); new or worsening heart failure; new or worsening psoriasis; allergic reactions; autoimmune reactions, including a lupus-like syndrome and autoimmune hepatitis.

Common side effects include: Injection site reactions and upper respiratory infections (sinus infections).

In general, side effects in children were similar in frequency and type as those seen in adult patients. The types of infections reported were generally mild and similar to those usually seen in children.

These are not all the side effects with ENBREL. Tell your healthcare provider about any side effect that bothers you or does not go away.

If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see Prescribing Information and Medication Guide.

Indications

Moderate to Severe Rheumatoid Arthritis (RA)

ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.

Psoriatic Arthritis

ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used with or without methotrexate.

Moderate to Severe Plaque Psoriasis

ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years and older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light).

Ankylosing Spondylitis (AS)

ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.

Moderately to Severely Active Polyarticular Juvenile Idiopathic Arthritis (JIA)

ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Amgen is under license.

References: 1. Parsabiv® (etelcalcetide) prescribing information, Amgen. 2. Data on file, Amgen; [Summary of Clinical Efficacy; 2015]. 3. Alexander ST, et al. Mol Pharmacol. 2015;88:853-865. 4. Data on file, Amgen; [Report R20130052, 2014]. 5. Chen P, et al. CPT Pharmacometrics Syst Pharmacol. 2016;5:484-494. 6. Sensipar® (cinacalcet) prescribing information, Amgen. 7. Ma JN, et al. J Pharmacol Exp Ther. 2011;337:275-284.
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.